Amgen Inc. (AMGN)
USD 258.78
(-2.7%)
USD 258.78
(-2.7%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.87 Billion USD | 14.4% |
| 2022 | 10.35 Billion USD | -0.29% |
| 2021 | 10.38 Billion USD | 2.52% |
| 2020 | 10.12 Billion USD | 8.51% |
| 2019 | 9.33 Billion USD | -0.54% |
| 2018 | 9.38 Billion USD | 6.54% |
| 2017 | 8.8 Billion USD | -2.52% |
| 2016 | 9.03 Billion USD | 0.78% |
| 2015 | 8.96 Billion USD | -5.13% |
| 2014 | 9.45 Billion USD | -0.14% |
| 2013 | 9.46 Billion USD | 7.9% |
| 2012 | 8.77 Billion USD | -0.83% |
| 2011 | 8.84 Billion USD | 21.34% |
| 2010 | 7.28 Billion USD | 3.45% |
| 2009 | 7.04 Billion USD | -5.98% |
| 2008 | 7.49 Billion USD | 0.66% |
| 2007 | 7.44 Billion USD | 4.82% |
| 2006 | 7.1 Billion USD | 29.13% |
| 2005 | 5.5 Billion USD | 11.86% |
| 2004 | 4.91 Billion USD | 25.3% |
| 2003 | 3.92 Billion USD | 186.97% |
| 2002 | -4.51 Billion USD | -321.01% |
| 2001 | 2.04 Billion USD | 8.38% |
| 2000 | 1.88 Billion USD | 13.89% |
| 1999 | 1.65 Billion USD | 25.06% |
| 1998 | 1.32 Billion USD | 7.37% |
| 1997 | 1.23 Billion USD | 12.05% |
| 1996 | 1.09 Billion USD | 15.18% |
| 1995 | 954.3 Million USD | 25.91% |
| 1994 | 757.9 Million USD | 19.47% |
| 1993 | 634.4 Million USD | 47.19% |
| 1992 | 431 Million USD | -7.35% |
| 1991 | 465.2 Million USD | 217.33% |
| 1990 | 146.6 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.25 Billion USD | -14.61% |
| 2024 Q2 | 3.24 Billion USD | -0.4% |
| 2024 Q3 | 3.14 Billion USD | -2.99% |
| 2023 Q1 | 2.46 Billion USD | -13.91% |
| 2023 Q4 | 3.81 Billion USD | 23.96% |
| 2023 Q3 | 3.07 Billion USD | 23.58% |
| 2023 Q2 | 2.48 Billion USD | 1.01% |
| 2023 FY | 11.84 Billion USD | 14.4% |
| 2022 Q1 | 2.17 Billion USD | -22.91% |
| 2022 Q2 | 2.9 Billion USD | 33.58% |
| 2022 Q4 | 2.86 Billion USD | 19.05% |
| 2022 FY | 10.35 Billion USD | -0.29% |
| 2022 Q3 | 2.4 Billion USD | -17.33% |
| 2021 Q4 | 2.82 Billion USD | 3.86% |
| 2021 FY | 10.38 Billion USD | 2.52% |
| 2021 Q1 | 2.28 Billion USD | -24.66% |
| 2021 Q2 | 2.55 Billion USD | 12.01% |
| 2021 Q3 | 2.71 Billion USD | 6.38% |
| 2020 Q2 | 2.39 Billion USD | 4.45% |
| 2020 Q3 | 2.4 Billion USD | 0.58% |
| 2020 Q4 | 3.02 Billion USD | 25.74% |
| 2020 Q1 | 2.29 Billion USD | -20.82% |
| 2020 FY | 10.12 Billion USD | 8.51% |
| 2019 Q2 | 2.18 Billion USD | 7.44% |
| 2019 FY | 9.33 Billion USD | -0.54% |
| 2019 Q4 | 2.89 Billion USD | 30.16% |
| 2019 Q3 | 2.22 Billion USD | 2.02% |
| 2019 Q1 | 2.03 Billion USD | -26.24% |
| 2018 Q3 | 2.54 Billion USD | 15.48% |
| 2018 FY | 9.38 Billion USD | 6.54% |
| 2018 Q1 | 1.88 Billion USD | -24.58% |
| 2018 Q4 | 2.75 Billion USD | 8.18% |
| 2018 Q2 | 2.2 Billion USD | 16.93% |
| 2017 Q4 | 2.49 Billion USD | 6.57% |
| 2017 FY | 8.8 Billion USD | -2.52% |
| 2017 Q1 | 1.87 Billion USD | -22.21% |
| 2017 Q2 | 2.08 Billion USD | 11.24% |
| 2017 Q3 | 2.34 Billion USD | 12.26% |
| 2016 Q1 | 2.1 Billion USD | -13.36% |
| 2016 FY | 9.03 Billion USD | 0.78% |
| 2016 Q4 | 2.41 Billion USD | 6.91% |
| 2016 Q3 | 2.25 Billion USD | -0.04% |
| 2016 Q2 | 2.25 Billion USD | 7.17% |
| 2015 Q2 | 2.2 Billion USD | 11.48% |
| 2015 FY | 8.96 Billion USD | -5.13% |
| 2015 Q1 | 1.97 Billion USD | -26.44% |
| 2015 Q3 | 2.35 Billion USD | 6.58% |
| 2015 Q4 | 2.43 Billion USD | 3.49% |
| 2014 Q4 | 2.68 Billion USD | 7.69% |
| 2014 Q1 | 2.06 Billion USD | -26.05% |
| 2014 FY | 9.45 Billion USD | -0.14% |
| 2014 Q3 | 2.49 Billion USD | 13.65% |
| 2014 Q2 | 2.19 Billion USD | 6.29% |
| 2013 FY | 9.46 Billion USD | 7.9% |
| 2013 Q4 | 2.79 Billion USD | 23.02% |
| 2013 Q2 | 2.34 Billion USD | 14.23% |
| 2013 Q1 | 2.05 Billion USD | -17.29% |
| 2013 Q3 | 2.27 Billion USD | -3.07% |
| 2012 Q1 | 1.89 Billion USD | 50.28% |
| 2012 Q3 | 2.19 Billion USD | -0.68% |
| 2012 FY | 8.77 Billion USD | -0.83% |
| 2012 Q4 | 2.48 Billion USD | 13.24% |
| 2012 Q2 | 2.2 Billion USD | 16.6% |
| 2011 Q3 | 2.81 Billion USD | 38.96% |
| 2011 Q4 | 1.25 Billion USD | -55.26% |
| 2011 Q1 | 1.84 Billion USD | -15.99% |
| 2011 FY | 8.84 Billion USD | 21.34% |
| 2011 Q2 | 2.02 Billion USD | 9.52% |
| 2010 Q4 | 2.2 Billion USD | 25.77% |
| 2010 Q2 | 1.73 Billion USD | 8.17% |
| 2010 Q3 | 1.75 Billion USD | 0.92% |
| 2010 FY | 7.28 Billion USD | 3.45% |
| 2010 Q1 | 1.6 Billion USD | -25.37% |
| 2009 Q3 | 1.66 Billion USD | -3.65% |
| 2009 Q1 | 1.5 Billion USD | -26.8% |
| 2009 FY | 7.04 Billion USD | -5.98% |
| 2009 Q2 | 1.72 Billion USD | 14.62% |
| 2009 Q4 | 2.14 Billion USD | 29.24% |
| 2008 FY | 7.49 Billion USD | 0.66% |
| 2008 Q3 | 1.71 Billion USD | -17.15% |
| 2008 Q4 | 2.05 Billion USD | 19.88% |
| 2008 Q1 | 1.65 Billion USD | -11.8% |
| 2008 Q2 | 2.07 Billion USD | 25.3% |
| 2007 FY | 7.44 Billion USD | 4.82% |
| 2007 Q1 | 1.69 Billion USD | 60.82% |
| 2007 Q2 | 2.04 Billion USD | 20.35% |
| 2007 Q4 | 1.87 Billion USD | 2.02% |
| 2007 Q3 | 1.83 Billion USD | -10.0% |
| 2006 Q3 | 1.8 Billion USD | 5.01% |
| 2006 Q1 | 1.43 Billion USD | -13.74% |
| 2006 FY | 7.1 Billion USD | 29.13% |
| 2006 Q4 | 1.05 Billion USD | -41.48% |
| 2006 Q2 | 1.71 Billion USD | 19.85% |
| 2005 FY | 5.5 Billion USD | 11.86% |
| 2005 Q3 | 1.3 Billion USD | -3.34% |
| 2005 Q2 | 1.34 Billion USD | 13.55% |
| 2005 Q1 | 1.18 Billion USD | 23.75% |
| 2005 Q4 | 1.65 Billion USD | 27.22% |
| 2004 Q2 | 1.14 Billion USD | 9.71% |
| 2004 Q4 | 960 Million USD | -45.82% |
| 2004 FY | 4.91 Billion USD | 25.3% |
| 2004 Q3 | 1.77 Billion USD | 55.06% |
| 2004 Q1 | 1.04 Billion USD | -13.4% |
| 2003 Q2 | 894.9 Million USD | 9.71% |
| 2003 Q4 | 1.2 Billion USD | 19.03% |
| 2003 Q1 | 815.7 Million USD | 113.05% |
| 2003 Q3 | 1.01 Billion USD | 12.93% |
| 2003 FY | 3.92 Billion USD | 186.97% |
| 2002 Q1 | 447.5 Million USD | -41.33% |
| 2002 Q4 | -6.25 Billion USD | -945.66% |
| 2002 FY | -4.51 Billion USD | -321.01% |
| 2002 Q3 | 739.2 Million USD | 56.48% |
| 2002 Q2 | 472.4 Million USD | 5.56% |
| 2001 Q3 | 444.2 Million USD | 1.21% |
| 2001 Q4 | 762.7 Million USD | 71.7% |
| 2001 Q2 | 438.9 Million USD | 10.92% |
| 2001 FY | 2.04 Billion USD | 8.38% |
| 2001 Q1 | 395.7 Million USD | -28.6% |
| 2000 Q4 | 554.2 Million USD | 20.93% |
| 2000 FY | 1.88 Billion USD | 13.89% |
| 2000 Q3 | 458.3 Million USD | -0.56% |
| 2000 Q2 | 460.9 Million USD | 12.33% |
| 2000 Q1 | 410.3 Million USD | -17.08% |
| 1999 Q1 | 365.3 Million USD | -2.35% |
| 1999 Q3 | 397.7 Million USD | 0.4% |
| 1999 FY | 1.65 Billion USD | 25.06% |
| 1999 Q4 | 494.8 Million USD | 24.42% |
| 1999 Q2 | 396.1 Million USD | 8.43% |
| 1998 Q3 | 335.7 Million USD | 7.94% |
| 1998 FY | 1.32 Billion USD | 7.37% |
| 1998 Q4 | 374.1 Million USD | 11.44% |
| 1998 Q1 | 301.7 Million USD | -3.58% |
| 1998 Q2 | 311 Million USD | 3.08% |
| 1997 Q4 | 312.9 Million USD | -3.01% |
| 1997 Q3 | 322.6 Million USD | 7.68% |
| 1997 Q2 | 299.6 Million USD | 1.01% |
| 1997 Q1 | 296.6 Million USD | 1.19% |
| 1997 FY | 1.23 Billion USD | 12.05% |
| 1996 Q2 | 266.9 Million USD | 0.6% |
| 1996 Q4 | 293.1 Million USD | 7.01% |
| 1996 FY | 1.09 Billion USD | 15.18% |
| 1996 Q1 | 265.3 Million USD | 2.95% |
| 1996 Q3 | 273.9 Million USD | 2.62% |
| 1995 Q4 | 257.7 Million USD | 10.08% |
| 1995 FY | 954.3 Million USD | 25.91% |
| 1995 Q2 | 235.5 Million USD | 3.74% |
| 1995 Q1 | 227 Million USD | 12.32% |
| 1995 Q3 | 234.1 Million USD | -0.59% |
| 1994 Q1 | 173 Million USD | -2.2% |
| 1994 FY | 757.9 Million USD | 19.47% |
| 1994 Q4 | 202.1 Million USD | 4.28% |
| 1994 Q3 | 193.8 Million USD | 2.49% |
| 1994 Q2 | 189.1 Million USD | 9.31% |
| 1993 Q2 | 158.6 Million USD | 11.22% |
| 1993 Q3 | 156.3 Million USD | -1.45% |
| 1993 Q4 | 176.9 Million USD | 13.18% |
| 1993 FY | 634.4 Million USD | 47.19% |
| 1993 Q1 | 142.6 Million USD | 144.6% |
| 1992 Q3 | 139.8 Million USD | 9.13% |
| 1992 Q4 | 58.3 Million USD | -58.3% |
| 1992 Q1 | 104.8 Million USD | 4.49% |
| 1992 FY | 431 Million USD | -7.35% |
| 1992 Q2 | 128.1 Million USD | 22.23% |
| 1991 Q1 | 70.8 Million USD | -34.2% |
| 1991 Q3 | 88.7 Million USD | -56.84% |
| 1991 Q4 | 100.3 Million USD | 13.08% |
| 1991 FY | 465.2 Million USD | 217.33% |
| 1991 Q2 | 205.5 Million USD | 190.25% |
| 1990 FY | 146.6 Million USD | 0.0% |
| 1990 Q1 | 40.5 Million USD | -17.85% |
| 1990 Q2 | 45.5 Million USD | 12.35% |
| 1990 Q4 | 107.6 Million USD | 110.98% |
| 1990 Q3 | 51 Million USD | 12.09% |
| 1989 Q2 | 26.5 Million USD | 135.33% |
| 1989 Q1 | -75 Million USD | 0.0% |
| 1989 Q4 | 49.3 Million USD | 62.71% |
| 1989 Q3 | 30.3 Million USD | 14.34% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AstraZeneca PLC | 29.57 Billion USD | 59.842% |
| Biogen Inc. | 5.2 Billion USD | -128.208% |
| Gilead Sciences, Inc. | 13.01 Billion USD | 8.722% |
| MIRA Pharmaceuticals, Inc. | 8.52 Million USD | -139214.219% |
| Scilex Holding Company | 136.49 Million USD | -8602.278% |
| Scilex Holding Company | 136.49 Million USD | -8602.278% |